BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 32322742)

  • 41. A multicenter, randomized, open label comparison of azithromycin and amoxicillin/clavulanate in acute otitis media among children attending day care or school.
    Khurana CM
    Pediatr Infect Dis J; 1996 Sep; 15(9 Suppl):S24-9. PubMed ID: 8878243
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of cefditoren pivoxil and amoxicillin/clavulanate in the treatment of pediatric patients with acute bacterial rhinosinusitis in Thailand: a randomized, investigator-blinded, controlled trial.
    Poachanukoon O; Kitcharoensakkul M
    Clin Ther; 2008 Oct; 30(10):1870-9. PubMed ID: 19014842
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cefprozil versus high-dose amoxicillin/clavulanate in children with acute otitis media.
    Hedrick JA; Sher LD; Schwartz RH; Pierce P
    Clin Ther; 2001 Feb; 23(2):193-204. PubMed ID: 11293553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized, double-blind, placebo-controlled noninferiority trial of amoxicillin for clinically diagnosed acute otitis media in children 6 months to 5 years of age.
    Le Saux N; Gaboury I; Baird M; Klassen TP; MacCormick J; Blanchard C; Pitters C; Sampson M; Moher D
    CMAJ; 2005 Feb; 172(3):335-41. PubMed ID: 15684116
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome.
    Weiden PJ; Schooler NR; Weedon JC; Elmouchtari A; Sunakawa A; Goldfinger SM
    J Clin Psychiatry; 2009 Oct; 70(10):1397-406. PubMed ID: 19906343
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ambulatory Treatment of Fast Breathing in Young Infants Aged <60 Days: A Double-Blind, Randomized, Placebo-Controlled Equivalence Trial in Low-Income Settlements of Karachi.
    Tikmani SS; Muhammad AA; Shafiq Y; Shah S; Kumar N; Ahmed I; Azam I; Pasha O; Zaidi AK
    Clin Infect Dis; 2017 Jan; 64(2):184-189. PubMed ID: 27941119
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes.
    Dohar J; Giles W; Roland P; Bikhazi N; Carroll S; Moe R; Reese B; Dupre S; Wall M; Stroman D; McLean C; Crenshaw K
    Pediatrics; 2006 Sep; 118(3):e561-9. PubMed ID: 16880248
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systematic review on antibiotic therapy for pneumonia in children between 2 and 59 months of age.
    Lassi ZS; Das JK; Haider SW; Salam RA; Qazi SA; Bhutta ZA
    Arch Dis Child; 2014 Jul; 99(7):687-93. PubMed ID: 24431417
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A survey of caregivers of Nigerian children less than 6 years of age to determine the experience and perception of acceptability of oral solid dosage forms.
    Orubu S; Okwelogu C; Opanuga O; Tuleu C
    Int J Pharm; 2018 Feb; 536(2):582-589. PubMed ID: 29100913
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adherence to guidelines on the use of amoxicillin for treatment of ambulatory pneumonia in children younger than 5 years, Colombia, 2017-2019.
    Moyano Ariza L; Ochoa B; Shewade HD; Edwards JK; Trujillo Trujillo J; Cuellar CM; Rodríguez J; Hann K; Sanchez M
    Rev Panam Salud Publica; 2023; 47():e52. PubMed ID: 37082539
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomized, investigator-blinded, multicenter study of gatifloxacin versus amoxicillin/clavulanate treatment of recurrent and nonresponsive otitis media in children.
    Sáez-Llorens X; Rodriguez A; Arguedas A; Hamed KA; Yang J; Pierce P; Echols R
    Pediatr Infect Dis J; 2005 Apr; 24(4):293-300. PubMed ID: 15818287
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of the new dispersible fixed-dose combination anti-Tuberculosis drug on treatment adherence among children with Tuberculosis in Osun State, Nigeria.
    Chijioke-Akaniro O; Akinyemi PA; Asuke S; Anyaike C; Uwaezuoke NA; Ochuko U; Ubochioma E; Omoniyi A; Merle CS; Daniel S
    Int Health; 2023 Nov; ():. PubMed ID: 37971028
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Time to reconsider routine high-dose amoxicillin for community-acquired pneumonia in all Canadian children.
    Rajapakse NS; Vayalumkal JV; Vanderkooi OG; Ricketson LJ; Kellner JD
    Paediatr Child Health; 2016 Mar; 21(2):65-6. PubMed ID: 27095876
    [No Abstract]   [Full Text] [Related]  

  • 54. Five vs 10 day amoxicillin course for pneumonia.
    Bonadio W
    J Pediatr; 2021 Sep; 236():325-328. PubMed ID: 34446178
    [No Abstract]   [Full Text] [Related]  

  • 55. Development and content validation of the Pediatric Oral Medicines Acceptability Questionnaires (P-OMAQ): patient-reported and caregiver-reported outcome measures.
    Turner-Bowker DM; An Haack K; Krohe M; Yaworsky A; Vivas N; Kelly M; Chatterjee G; Chaston E; Mann E; Reaney M
    J Patient Rep Outcomes; 2020 Oct; 4(1):80. PubMed ID: 33000327
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Challenges of Antibiotic Formulations and Administration in the Treatment of Bloodstream Infections in Children Under Five Admitted to Kisantu Hospital, Democratic Republic of Congo.
    Tack B; Vita D; Ntangu E; Ngina J; Mukoko P; Lutumba A; Vangeluwe D; Toelen J; Allegaert K; Lunguya O; Ravinetto R; Jacobs J
    Am J Trop Med Hyg; 2023 Dec; 109(6):1245-1259. PubMed ID: 37903440
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Paediatric medicine issues and gaps from healthcare workers point of view: survey results and a narrative review from the global accelerator for paediatric formulations project.
    Barbieri E; Minotti C; Cavagnis S; Giaquinto C; Cappello B; Penazzato M; Lallemant M
    Front Pharmacol; 2023; 14():1200848. PubMed ID: 37529704
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Harmonization of Amoxicillin Dose, Duration, and Formulation for Acute Childhood Respiratory Infections.
    Dharmapalan D; Bielicki J; Sharland M
    Antibiotics (Basel); 2023 Jun; 12(7):. PubMed ID: 37508234
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Orally Dispersible Dosage Forms for Paediatric Use: Current Knowledge and Development of Nanostructure-Based Formulations.
    Cornilă A; Iurian S; Tomuță I; Porfire A
    Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015247
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.